Monitoring the safety and performance of Ennovate® Cervical implants

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects data on the safety and performance of the Ennovate® Cervical system used in patients with various spinal conditions. It aims to document clinical outcomes and evaluate the efficacy of the implant system in treating spine fractures, degenerative disc disease, spinal instability, spinal tumors, and degenerative myelopathy. The study involves multiple centers and focuses on gathering detailed information from patients who have received the implant, ensuring comprehensive follow-up and assessment of results.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient is minimum 18 years old
* Informed Consent in the documentation of clinical and radiological results
* Patient has indication according to Instructions for Use (IFU)
* Patient is not pregnant

Exclusion Criteria:

* Patient's clear unability or unwillingness to participate in follow-up examinations

Where it's running

• Berufsgenossenschaft Klinikum Bergmannstrost Halle / Saale
  Halle, Saxony-Anhalt, Germany Recruiting
• Schön Klinik Hamburg Eilbek
  Hamburg, Free and Hanseatic City of Hamburg, Germany Active not recruiting
• Krankenhaus Ludmillenstift Meppen
  Meppen, Lower Saxony, Germany Not yet recruiting
• Städtisches Klinikum Dresden
  Dresden, Saxony, Germany Not yet recruiting

Study contacts

• Study coordinator: Sarah Mattes
• Email: sarah.mattes@aesculap.de
• Phone: +497461950

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heart-friendly medicines to protect chest-area cancer patients from radiation damage

  This Phase 2 trial tests whether taking atorvastatin and lisinopril can reduce heart damage in adults with chest-area cancers who receive radiation therapy.

  Recruiting Phase 2 UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07685938

• Radiotherapy after Separation Surgery for Spinal Metastases

  This study tests whether giving radiotherapy after separation surgery helps people with spinal metastases live longer and feel better.

  Recruiting Shanghai Changzheng Hospital · Shanghai, Shanghai Municipality · NCT07527884

• Comparing open and minimally invasive posterior stabilization for thoracic and lumbar spine fractures using 3D gait and muscle recordings

  This trial will test whether open or minimally invasive posterior stabilization leads to faster or different walking and back-muscle recovery after thoracic or lumbar spine fractures.

  Recruiting Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. · Ústí nad Labem, Ústí nad Labem Region · NCT07516834

• Bone marrow concentrate injection added to lumbar microdiscectomy

  This trial tests whether adding a bone marrow aspirate concentrate injection during lumbar microdiscectomy helps adults recover better than surgery alone.

  Recruiting Weill Medical College of Cornell University · Manhattan, New York · NCT07386548

• IDCT (Intradiscal Cell Therapy) for single-level mild-to-moderate lumbar degenerative disc disease

  This will test whether injecting IDCT (rebonuputemcel) into one degenerating lower-back disc can reduce chronic low back pain in adults with mild-to-moderate lumbar degenerative disc disease.

  Recruiting at 30 sites Phase 3 DiscGenics, Inc. · Birmingham, Alabama and 30 other locations · NCT07254806

• Novosis Putty used with transforaminal lumbar interbody fusion for lumbar degenerative disc disease

  The trial will test whether using Novosis Putty during transforaminal lumbar interbody fusion helps adults with lumbar degenerative disc disease heal better compared with standard care.

  Recruiting at 8 sites Phase 3 CGBio Inc. · Little Rock, Arkansas and 9 other locations · NCT07017634

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.